We are here to help.
Learn more about the Omnipod Insulin Pump System Mass Tort
or call 1 (866) 308-7722 for a free consultation.
What Is the Omnipod System?
The Omnipod System, manufactured by Insulet Corporation, includes products such as the Omnipod 5 Automated Insulin Delivery System, Omnipod 5 Pod, Omnipod DASH, Omnipod DASH Pods, and Omnipod Insulin Management System / Omnipod Eros pods. These systems are designed to provide continuous insulin delivery for diabetes management.
What Are the Alleged Problems With the Omnipod System?
The Omnipod systems are subject to allegations of a manufacturing defect involving a tear in the internal tubing or a compromise of the insulin fluid path. This defect can cause insulin to leak inside the Pod, potentially leading to reduced or interrupted insulin delivery. Such interruptions can result in high blood glucose levels, diabetic ketoacidosis (DKA), hospitalization, and other life-threatening consequences.
A voluntary Medical Device Correction was issued on March 12, 2026, followed by a Health Canada Urgent Medical Device Recall on May 26, 2026, which expanded to include Omnipod 5, DASH, and Omnipod Insulin Management System pods in Canada.
What Is This Mass Tort Claim About?
This mass tort claim concerns allegations of a manufacturing defect in Omnipod insulin pump systems that could lead to insulin leakage and underdelivery. The claim focuses on whether Insulet Corporation was negligent in the research, design, manufacturing, distribution, sale, and post-market monitoring of these devices, and whether they failed to warn users of the potential risks.
Legal Basis for the Claims
Potential claims that may be advanced include the following:
- Negligence: Allegations that Insulet Corporation failed to exercise reasonable care in the design, manufacturing, and distribution of the Omnipod system
- Failure to Warn: Allegations that Insulet Corporation did not adequately warn users about the risks associated with the alleged defect
- Breach of Warranty: Allegations that the Omnipod devices did not meet implied or express warranties of fitness for purpose of use
- Consumer Protection Act Claims: Claims under provincial consumer protection legislation related to product defects and representations
Why a Mass Tort?
A mass tort action is considered more appropriate than a class action for this matter. This is because a limited number of individuals are likely to have compensable damages, as free replacement devices may have reduced the compensable loss for many users. Mere exposure to risk is generally not compensable in law. Stronger claims exist for individuals who suffered actual, serious harm and individualized damages, such as hospitalization or diabetic ketoacidosis. A mass tort approach is well-suited for cases where each seriously injured plaintiff can prove individualized causation and damages.
Related FAQS.
Which Omnipod Products are Affected by the Recall?
Insulet Corporation issued a series of voluntary and urgent recalls in 2026 after finding a manufacturing defect in the insulin fluid path of certain Omnipod devices. This defect can reduce or interrupt insulin delivery, leading to dangerously high blood sugar or, in serious cases, diabetic ketoacidosis (DKA). Knowing which products fall under the recall helps you act quickly and protect your health.
Which Omnipod Product Lines Are Included?
The recalls affect specific lots across three product lines. Importantly, only certain lots within each line are involved, so owning one of these models does not automatically mean your device is recalled.
- Omnipod 5
- Omnipod DASH
- Omnipod Eros
It is important to check your pod's lot number against Insulet's official recall notices to determine whether your device is affected.
- Class Action
- Gluckstein main site